BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bertani H, Frazzoni M, Mangiafico S, Caruso A, Manno M, Mirante VG, Pigò F, Barbera C, Manta R, Conigliaro R. Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy. World J Gastrointest Endosc 2015; 7(6): 582-592 [PMID: 26078827 DOI: 10.4253/wjge.v7.i6.582] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Benzing C, Schmelzle M, Atik CF, Krenzien F, Mieg A, Haiden LM, Wolfsberger A, Schöning W, Fehrenbach U, Pratschke J. Factors associated with failure to rescue after major hepatectomy for perihilar cholangiocarcinoma: A 15-year single-center experience. Surgery 2022. [DOI: 10.1016/j.surg.2021.08.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Guardado NV, Llorente K, Blondeau B. Evaluation and Management of Malignant Biliary Obstruction. Surg Oncol Clin N Am 2021;30:491-503. [PMID: 34053664 DOI: 10.1016/j.soc.2021.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang J, Zhou H, Wang Y, Huang H, Yang J, Gu W, Zhang X, Yang J. Serum mucin 3A as a potential biomarker for extrahepatic cholangiocarcinoma. Saudi J Gastroenterol 2020;26:129-36. [PMID: 32270773 DOI: 10.4103/sjg.SJG_447_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Saccomandi P, Quero G, Gassino R, Lapergola A, Guerriero L, Diana M, Vallan A, Perrone G, Schena E, Costamagna G, Marescaux J, Di Matteo FM. Laser ablation of the biliary tree: in vivo proof of concept as potential treatment of unresectable cholangiocarcinoma. Int J Hyperthermia 2018;34:1372-80. [PMID: 29322853 DOI: 10.1080/02656736.2018.1427287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Parikh MP, Sanaka MR. Endoscopic Management of Hepatobiliary Complications of Inflammatory Bowel Disease. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications 2018. [DOI: 10.1016/b978-0-12-811388-2.00020-8] [Reference Citation Analysis]
6 Wirth TC, Vogel A. Surveillance in cholangiocellular carcinoma. Best Pract Res Clin Gastroenterol 2016;30:987-99. [PMID: 27938792 DOI: 10.1016/j.bpg.2016.11.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
7 Cannavale A, Santoni M, Gazzetti M, Maher B, Fanelli F, Fiocca F, Catalano C. Updated Management of Malignant Biliary Tract Tumors: An Illustrative Review. Journal of Vascular and Interventional Radiology 2016;27:1056-69. [DOI: 10.1016/j.jvir.2016.01.149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]